SGO Issues Aug. 23, 2018
New from Elsevier: Molecular Tumor Board Presentation
Send comments to CMS by Sept. 10 to avoid payment cuts
Cervical cancer articles in September 2018 Gynecologic Oncology
Aug. 27 deadline for FWC Research and Grant Awards
With the rapid expansion in our understanding of cancer genetics, Gynecologic Oncology is launching a new feature, the Molecular Tumor Board Presentation. This series aims to incorporate tumor molecular profiling and genetics into clinical care and decision making for patients with a variety of gynecologic cancers. Cases will be presented by multidisciplinary teams from the perspective of genomic alterations as well as histopathology. The goal of these presentations will be to provide readers with useful information that will help to improve patient care through personalized and targeted approaches. Read the latest Molecular Tumor Board Presentation: “Durable response in a woman with recurrent low-grade endometrioid endometrial cancer and a germline BRCA2 mutation treated with a PARP inhibitor.”
Editor-in-Chief’s Featured Cover Articles from the August issue:
- State of the Science: Hormonal strategies in gynecologic cancer: Bridging biology and therapy
- Lead Article: Factors that influence survival in high-grade serous ovarian cancer: A complex relationship between molecular subtype, disease dissemination, and operability. Be sure to check out the corresponding Editorial by Douglas Levine
- Surgical Film: Uterine transposition after radical trachelectomy with a Clinical Commentary by Marcela del Carmen
- Review: Adoptive cell transfer using autologous tumor infiltrating lymphocytes in gynecologic malignancies
- Ovarian Germ Cell Tumors: Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?
View the entire August lineup online.
The Centers for Medicare and Medicaid Services (CMS) has proposed changes to both the documentation requirements and payments for Evaluation & Management (E&M) codes as part of the 2019 Proposed Medicare Physician Fee Schedule. In addition to the proposed single, blended payment for Level 2 -5 E&M codes for new patient visits ($135) and established patient visits ($93), there are several other factors that will affect these payments. The American Medical Association conducted an impact analysis for all specialties and sub-specialties with two-digit specialty codes; gynecologic oncology’s impact is a negative 16 percent. SGO has prepared a sample comment letter to personalize with instructions on how to submit a letter to CMS. Submit comments to CMS on this issue by Sept. 10, 2018 at 5:00 pm EDT and send a copy of the letter to Jill_Rathbun@galileogrp.com.
- Go to http://www.regulations.gov
- Search for: CMS-1693-P and the information below should appear at the top of the page:
Medicare Program: Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2019; Medicare Shared Savings Program Requirements; etc.
Proposed Rule by CMS on 07/27/2018 ID: CMS-2018-0076-0621
- Next, click on “Comment Now”
- Upload your comments, fill in the rest of the information requested in the boxes and hit continue to see a draft and then push the “send” button.
If you have any questions, please contact Jill Rathbun at Jill_Rathbun@galileogrp.com or 703-217-7224.
This month’s Gynecologic Oncology journal is highlighting articles on cervical cancer. This includes a Historical Perspective, “Twenty-first century cervical cancer management: A historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years,” by Charles A. Leath III, Bradley J. Monk; and a Gynecologic Oncology Tumor Board Presentation on “Locally advanced cervical cancer complicating pregnancy: A case of competing risks from the Catholic University of the Sacred Heart in Rome,” by R. De Vincenzo, L. Tortorella, C. Ricci, A.F. Cavaliere, G.F. Zannoni, M.G. Cefalo, G. Scambia, A. Fagotti.
Applications are still being accepted for the 2018-2019 Foundation for Women’s Cancer Research Grants and Awards program. Sixteen research grants and prizes totaling $747,500 will be awarded. Research grant abstracts are due on Monday, Aug. 27, 2018, and Fellow-in-Training and Research Prize applications will remain open until Nov. 26, 2018.